Ascending Investigator
Timothy Patrick Jenkins
Multi-target acute GPCR inhibitors for migraine delivered via intranasal mRNA-encoded binders
This project pioneers a new approach to migraine treatment by combining AI-designed protein medicines with intranasal mRNA delivery for rapid, needle-free relief. By accelerating the development process and working closely with clinical experts, we aim to create safer, fast-acting therapies that can improve the lives of people affected by migraine and potentially transform care for related brain disorders.
